Inventor profile of:

Scott E. Lazerwith

City:

San Francisco, California

Country:

United States

Published Applications:

53

Last publication date:

2026-06-18

Top Assignees for applications by Scott E. Lazerwith

The entities that hold a legal rights for patent applications filed by inventor Lazerwith Scott E.:

Recent patent applications by Lazerwith Scott E.

Scott E. Lazerwith from San Francisco, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-06-18
US20260167650A1
Chemistry; metallurgy

KRAS MODULATING COMPOUNDS

#2 | 2026-04-30
US20260116882A1
Chemistry; metallurgy

KRAS G12D MODULATING COMPOUNDS

#3 | 2026-04-09
US20260098049A1
Chemistry; metallurgy

KRAS MODULATING COMPOUNDS

#4 | 2025-07-17
US20250230168A1
Chemistry; metallurgy

AZASPIRO WRN INHIBITORS

#5 | 2025-05-15
US20250154116A1
Chemistry; metallurgy

MCL-1 INHIBITORS

#6 | 2025-05-01
US20250136621A1
Chemistry; metallurgy

KRAS G12D MODULATING COMPOUNDS

#7 | 2025-04-03
US20250109147A1
Chemistry; metallurgy

KRAS G12D MODULATING COMPOUNDS

#8 | 2025-03-27
US20250101042A1
Chemistry; metallurgy

KRAS G12D MODULATING COMPOUNDS

#9 | 2025-02-13
US20250049780A1
Human necessities

THIENOPYRROLE COMPOUNDS

#10 | 2025-02-06
US20250042922A1
Chemistry; metallurgy

KRAS MODULATING COMPOUNDS

#11 | 2025-02-06
US20250042915A1
Chemistry; metallurgy

SARS-COV2 MAIN PROTEASE INHIBITORS

#12 | 2025-01-02
US20250002471A1
Chemistry; metallurgy

6-SUBSTITUTED INDOLE COMPOUNDS

#13 | 2024-11-21
US20240383922A1
Chemistry; metallurgy

KRAS Modulating Compounds

#14 | 2024-07-18
US20240239807A1
Chemistry; metallurgy

SARS-COV2 MAIN PROTEASE INHIBITORS

#15 | 2024-07-04
US20240217990A1
Chemistry; metallurgy

THIENOPYRROLE COMPOUNDS

#16 | 2024-04-11
US20240116946A1
Chemistry; metallurgy

SARS-COV2 main protease inhibitors

#17 | 2024-02-22
US20240059673A1
Chemistry; metallurgy

SUBSTITUTED INDOLE COMPOUNDS

#18 | 2024-01-25
US20240025932A1
Chemistry; metallurgy

PHOSPHOLIPID COMPOUNDS AND USES THEREOF

#19 | 2023-11-23
US20230374036A1
Chemistry; metallurgy

KRAS G12D MODULATING COMPOUNDS

#20 | 2023-11-16
US20230365594A1
Chemistry; metallurgy

THIENOPYRROLE COMPOUNDS

#21 | 2023-10-26
US20230339981A1
Chemistry; metallurgy

KRAS G12D MODULATING COMPOUNDS

#22 | 2023-10-05
US20230312567A1
Chemistry; metallurgy

Capsid inhibitors for the treatment of HIV

#23 | 2023-10-05
US20230312490A1
Chemistry; metallurgy

MCL-1 inhibitors

#24 | 2023-08-10
US20230250117A1
Chemistry; metallurgy

Phospholipid compounds and uses thereof

#25 | 2023-08-10
US20230248753A1
Human necessities

Phospholipid compounds and uses thereof

#26 | 2017-05-11
US20170128443A1
Human necessities

Polycyclic-carbamoylpyridone compounds and their pharmaceutical use

#27 | 2017-04-27
US20170114074A1
Chemistry; metallurgy

POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE

#28 | 2017-03-02
US20170057976A1
Chemistry; metallurgy

Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]OXAZEPINES and methods for treating viral infections

#29 | 2017-02-02
US20170029408A1
Chemistry; metallurgy

Antiviral compounds

#30 | 2016-12-22
US20160368918A1
Chemistry; metallurgy

Syk inhibitors

#31 | 2016-10-06
US20160289246A1
Chemistry; metallurgy

Polycyclic-carbamoylpyridone compounds and their pharmaceutical use

#32 | 2016-07-07
US20160194335A1
Chemistry; metallurgy

POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE

#33 | 2016-06-23
US20160176885A1
Chemistry; metallurgy

Substituted 1,2,3,4,6,8,12,12a-octahydro-1,4-methanodipyrido[1,2-a:1',2'-d]pyrazines and methods for treating viral infections

#34 | 2016-06-23
US20160176870A1
Chemistry; metallurgy

Polycyclic-carbamoylpyridone compounds and their pharmaceutical use

#35 | 2016-04-21
US20160108030A1
Chemistry; metallurgy

Therapeutic compounds

#36 | 2015-12-24
US20150368264A1
Chemistry; metallurgy

SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS

#37 | 2015-02-05
US20150038488A1
Chemistry; metallurgy

Substituted pyrrolidines as SYK inhibitors

#38 | 2015-01-15
US20150018298A1
Human necessities

Polycyclic-carbamoylpyridone compounds and their pharmaceutical use

#39 | 2014-09-04
US20140249074A1
Human necessities

Antiviral compounds

#40 | 2014-08-07
US20140221356A1
Chemistry; metallurgy

Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepines and methods for treating viral infections

#41 | 2014-08-07
US20140221355A1
Chemistry; metallurgy

POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE

#42 | 2014-02-20
US20140051656A1
Chemistry; metallurgy

Antiviral compounds

#43 | 2014-02-06
US20140039021A1
Chemistry; metallurgy

Antiviral compounds

#44 | 2014-01-30
US20140030223A1
Human necessities

INHIBITORS OF FLAVIVIRIDAE VIRUSES

#45 | 2013-12-05
US20130323203A1
Chemistry; metallurgy

Inhibitors of viruses

#46 | 2013-11-28
US20130315861A1
Chemistry; metallurgy

Inhibitors of viruses

#47 | 2013-05-30
US20130137877A1
Chemistry; metallurgy

Antiviral compounds

#48 | 2013-02-28
US20130052161A1
Chemistry; metallurgy

Inhibitors of flaviviridae viruses

#49 | 2011-07-21
US20110178129A1
Chemistry; metallurgy

Inhibitors of flaviviridae viruses

#50 | 2011-07-21
US20110178058A1
Chemistry; metallurgy

Inhibitors of viruses

#51 | 2011-05-26
US20110123493A1
Chemistry; metallurgy

2,4,6-trisubstituted pyrido(3,2-d)pyrimidines useful for treating viral infections

#52 | 2011-01-27
US20110020278A1
Human necessities

Inhibitors of flaviviridae viruses

#53 | 2008-10-23
US20080261941A1
Chemistry; metallurgy

Biaryl ether urea compounds

InventorID:

547095 ⎘